I. Friedrich

785 total citations
21 papers, 646 citations indexed

About

I. Friedrich is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, I. Friedrich has authored 21 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in I. Friedrich's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Pregnancy and preeclampsia studies (4 papers). I. Friedrich is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Pregnancy and preeclampsia studies (4 papers). I. Friedrich collaborates with scholars based in Germany, Austria and Israel. I. Friedrich's co-authors include Heinrich Wieland, Winfried März, Karl Winkler, Michael M. Hoffmann, Manfred W. Baumstark, B. Wetzka, Martina Kinner, C. Abletshauser, Hans-Peter Zahradnik and Thomas R. Konrad and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Journal of Lipid Research.

In The Last Decade

I. Friedrich

20 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Friedrich Germany 13 259 237 153 138 124 21 646
M Congiu Australia 17 148 0.6× 96 0.4× 329 2.2× 197 1.4× 131 1.1× 46 951
Welmoed Reitsma Netherlands 9 117 0.5× 281 1.2× 71 0.5× 94 0.7× 22 0.2× 11 642
S Kralisch Germany 18 125 0.5× 159 0.7× 54 0.4× 296 2.1× 39 0.3× 28 767
Elsy Velázquez Venezuela 6 56 0.2× 376 1.6× 111 0.7× 109 0.8× 87 0.7× 7 1.0k
Ana Lorenzo-Almorós Spain 10 92 0.4× 101 0.4× 90 0.6× 177 1.3× 41 0.3× 10 526
Hong Chang Tan Singapore 18 268 1.0× 148 0.6× 38 0.2× 151 1.1× 53 0.4× 56 798
Rong Luo China 11 72 0.3× 93 0.4× 48 0.3× 98 0.7× 115 0.9× 24 458
Soaira G. Mendoza United States 10 119 0.5× 310 1.3× 40 0.3× 58 0.4× 28 0.2× 11 582
Andrea Repaci Italy 18 204 0.8× 556 2.3× 32 0.2× 181 1.3× 30 0.2× 51 1.1k
Zhijuan Ge China 13 89 0.3× 100 0.4× 64 0.4× 216 1.6× 32 0.3× 22 542

Countries citing papers authored by I. Friedrich

Since Specialization
Citations

This map shows the geographic impact of I. Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Friedrich more than expected).

Fields of papers citing papers by I. Friedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Friedrich. The network helps show where I. Friedrich may publish in the future.

Co-authorship network of co-authors of I. Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of I. Friedrich. A scholar is included among the top collaborators of I. Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Friedrich. I. Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brockow, Inken, Mark Praetorius, Katrin Neumann, et al.. (2014). Universelles Neugeborenen-Hörscreening. HNO. 62(3). 165–170. 10 indexed citations
2.
3.
Goldmann, K., et al.. (2006). Videolaryngoskopie zur modifizierten „Rapid-sequence-Narkoseeinleitung“. Der Anaesthesist. 55(4). 407–413. 3 indexed citations
4.
Wunderlich, Thomas, et al.. (2006). Th-P16:397 Atorvastatin and LDL profile in NIDDM (ALPIN study). Atherosclerosis Supplements. 7(3). 581–581. 2 indexed citations
5.
Winkler, K., I. Friedrich, Paula M. Hauck, et al.. (2004). Qualitative Effect of Fenofibrate and Quantitative Effect of Atorvastatin on LDL Profile in Combined Hyperlipidemia with dense LDL. Experimental and Clinical Endocrinology & Diabetes. 112(5). 241–247. 24 indexed citations
6.
Winkler, Karl, C. Abletshauser, I. Friedrich, et al.. (2004). Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1153–1159. 58 indexed citations
7.
Wetzka, B., Michael M. Hoffmann, I. Friedrich, et al.. (2004). Transient Remnant Removal Disease in Acute Fatty Liver of Pregnancy. Hypertension in Pregnancy. 23(2). 143–153. 4 indexed citations
8.
Winkler, Karl, Thomas R. Konrad, I. Friedrich, et al.. (2003). Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension. Diabetes Care. 26(9). 2588–2594. 94 indexed citations
9.
Winkler, Karl, C. Abletshauser, Michael M. Hoffmann, et al.. (2002). Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action. The Journal of Clinical Endocrinology & Metabolism. 87(12). 5485–5490. 52 indexed citations
10.
Winkler, Karl, I. Friedrich, Manfred W. Baumstark, Heinrich Wieland, & Winfried März. (2002). Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus. The British Journal of Diabetes. 2(2). 143–148. 25 indexed citations
11.
Winkler, K., Juergen R. Schaefer, I. Friedrich, et al.. (2000). HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia. Atherosclerosis. 150(1). 113–120. 9 indexed citations
12.
Winkler, Karl, B. Wetzka, Michael M. Hoffmann, et al.. (2000). Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4543–4550. 74 indexed citations
13.
Friedrich, I. & Yishai Levy. (2000). [Diabetic ketoacidosis during the Ramadan fast].. PubMed. 138(1). 19–21, 86. 17 indexed citations
14.
Levy, Yishai, et al.. (2000). B vitamins substantially reduce plasma homocysteine in patients with diabetes mellitus. Atherosclerosis. 151(1). 17–17.
15.
Winkler, Karl, Hubert Scharnagl, U Tisljar, et al.. (1999). Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. Journal of Lipid Research. 40(3). 447–455. 50 indexed citations
16.
Wetzka, B., Karl Winkler, Martina Kinner, et al.. (1999). Altered Lipid Metabolism in Preeclampsia and HELLP Syndrome: Links to Enhanced Platelet Reactivity and Fetal Growth. Seminars in Thrombosis and Hemostasis. 25(5). 455–462. 22 indexed citations
17.
Orth, Matthias, et al.. (1996). Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1303(1). 22–30. 30 indexed citations
18.
Morgenstern, Daniel A., et al.. (1983). [Paroxysmal supraventricular tachycardia in the delivery room].. PubMed. 105(15). 1014–9. 2 indexed citations
19.
Behrens, U., I. Friedrich, Salvatore Vernace, Fenton Schaffner, & F Paronetto. (1982). Lymphocyte responsiveness per unit volume of blood in patients with chronic nonalcoholic and alcoholic liver disease. Plasma inhibitory factors and functional defects of responder cells.. PubMed. 8(3). 143–52. 1 indexed citations
20.
Friedrich, I., Gary P. Wormser, & Edward B. Gottfried. (1982). The association of remote Streptococcus bovis bacteremia with colonic neoplasia.. PubMed. 77(2). 82–4. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Congiu Breakdown of academic impact, for papers by Welmoed Reitsma Breakdown of academic impact, for papers by S Kralisch Breakdown of academic impact, for papers by Elsy Velázquez Breakdown of academic impact, for papers by Ana Lorenzo-Almorós Breakdown of academic impact, for papers by Hong Chang Tan Breakdown of academic impact, for papers by Rong Luo Breakdown of academic impact, for papers by Soaira G. Mendoza Breakdown of academic impact, for papers by Andrea Repaci Breakdown of academic impact, for papers by Zhijuan Ge
Rankless by CCL
2026